Jason Grebely

Active 2006–2025

176
Papers
22,483
Citations
82
h-index
165
i10-index

Citations

Citations per year for Jason Grebely1986: 3 citations1988: 1 citations2000: 2 citations2001: 1 citations2006: 2 citations2007: 6 citations2008: 5 citations2009: 11 citations2010: 23 citations2011: 29 citations2012: 29 citations2013: 123 citations2014: 73 citations2015: 124 citations2016: 152 citations2017: 177 citations2018: 302 citations2019: 1,222 citations2020: 948 citations2021: 841 citations2022: 620 citations2023: 492 citations2024: 949 citations2025: 247 citations2026: 4 citations1987: no citations, so this year is not shown1989–1999: no citations, so these years are not shown2002–2005: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,407 citing papers, 21.9% of this breakdownAustralia: 586 citing papers, 9.1% of this breakdownUnited Kingdom: 554 citing papers, 8.6% of this breakdownCanada: 453 citing papers, 7.1% of this breakdownChina: 252 citing papers, 3.9% of this breakdownItaly: 239 citing papers, 3.7% of this breakdownGermany: 224 citing papers, 3.5% of this breakdownSpain: 213 citing papers, 3.3% of this breakdownFrance: 185 citing papers, 2.9% of this breakdownSwitzerland: 137 citing papers, 2.2% of this breakdownNetherlands: 120 citing papers, 1.9% of this breakdownTaiwan: 110 citing papers, 1.7% of this breakdown
0%21.9%Other 30.2%

Fields

  • Medicine87.1%
  • Biochemistry, Genetics and Molecular Biology3.2%
  • Psychology1.8%
  • Neuroscience1.6%
  • Immunology and Microbiology1.5%
  • Health Professions1.5%
  • Other3.3%

Topics

  • Hepatitis C virus research17.6%
  • HIV, Drug Use, Sexual Risk9.6%
  • Hepatitis B Virus Studies8.8%
  • Liver Disease Diagnosis and Treatment7.5%
  • Opioid Use Disorder Treatment6.5%
  • Substance Abuse Treatment and Outcomes4.2%
  • Other45.8%

Coauthors

All papers

Open in search
  1. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ziv Ben‐Ari, Fernando Bessone, Mia J. Biondi, Abdul Rahman Bizri, Carlos Eduardo Brandão‐Mello, Krestina Brigida, Kimberly Brown, Robert S. Brown, Philip Bruggmann, Maurizia Rossana Brunetto, Dana Busschots, Marı́a Buti, Maia Butsashvili, Joaquín Cabezas, Chungman Chae, Viktorija Chaloska Ivanova, Henry Lik‐Yuen Chan, Hugo Cheinquer, Kent Jason G. Cheng, Myeong-Eun Cheon, Cheng‐Hung Chien, Rong‐Nan Chien, Gourdas Choudhuri, Peer Brehm Christensen, Wan‐Long Chuang, Vladimir Chulanov, Laura Cisneros, B. Coco, Fernando A Contreras, Markus Cornberg, Matthew Cramp, Javier Crespo, Fuqiang Cui, Chris Cunningham, Lucy Dagher Abou, Olav Dalgård, Doan Y Dao, Victor de Lédinghen, Moutaz Derbala, Keshab Deuba, Karan Dhindsa, Samsuridjal Djauzi, Sylvia Dražilová, Ann‐Sofi Duberg, Mohammed Elbadri, Manal H. El‐Sayed, Gamal Esmat, Chris Estes, Sameera Ezzat, Martti Färkkilâ, Laurent Ferradini, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Tajana Filipec Kanižaj, Robert Flisiak, Soňa Fraňková, James Fung, Amiran Gamkrelidze, Edward Gane, Virginia Garcia, Javier García‐Samaniego, Manik Gemilyan, Jordan Genov, Liliana Gheorghe, Pierre M. Gholam, Adrian Goldis, Magnús Gottfreðsson, Richard T. Gray, Jason Grebely, Michael Gschwantler and 158 more - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 653

  2. Global patterns of opioid use and dependence: harms to populations, interventions, and future action

    Authors: , , , , , , , , , , - The Lancet 2019 cited by 834

  3. Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence

    Authors: , , , , , , , , , , , , , , , , , , - JAMA Psychiatry 2021 cited by 583

  4. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

    Authors: , , , , , , , , , , , , , , - The Lancet Global Health 2017 cited by 1,478

  5. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

    Authors: , , , , , , , , , , , , , , , , - Addiction 2018 cited by 1,063

  6. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Global Health 2023 cited by 263

  7. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Abdullah M. Assiri, Oidov Baatarkhuu, Abate Bane, Ziv Ben‐Ari, Colm Bergin, Fernando Bessone, Florian Bihl, Abdul Rahman Bizri, Martin Blachier, Antonio Javier Blasco, Carlos Eduardo Brandão‐Mello, Philip Bruggmann, Cheryl Brunton, Filipe Calinas, Henry Lik‐Yuen Chan, Asad Chaudhry, Hugo Cheinquer, Chien‐Jen Chen, Rong‐Nan Chien, Moon Seok Choi, Peer Brehm Christensen, Wan‐Long Chuang, Vladimir Chulanov, Laura Cisneros, Mette Rye Clausen, Matthew Cramp, Antonio Craxı̀, Esther A. Croes, Olav Dalgård, Jorge Daruich, Victor de Lédinghen, Gregory J. Dore, Manal H. El‐Sayed, Gül Ergör, Gamal Esmat, Chris Estes, Karolin Falconer, Elmoubasher Farag, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Robert Flisiak, Soňa Fraňková, Ivane Gamkrelidze, Ed Gane, Javier García‐Samaniego, Amir Ghafoor Khan, Ilias Gountas, Adrian Goldis, Magnús Gottfreðsson, Jason Grebely, Michael Gschwantler, Mário Guimarães Pessôa, J. Gunter, Behzad Hajarizadeh, O. Hajelssedig, Saeed Hamid, Waseem Hamoudi, Angelos Hatzakis, Sayed Himatt, Harald Hofer, Irena Hrstić, Yee-Tak Hui, Béla Hunyady, Ramazan Idılman, Wasim Jafri, Rohani Jahis, Naveed Z. Janjua, Peter Jarčuška, Agita Jēruma, Jón G. Jónasson and 122 more - ˜The œLancet. Gastroenterology & hepatology 2016 cited by 2,032

  8. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 132

  9. openalex_id:w4220994910

    Authors: , , , , , , , , , , , , , , , , cited by 104

  10. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review

    Authors: , , , , , , , , , , , , , - The Lancet Global Health 2023 cited by 131

  11. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

    Authors: , , , , , , , - Journal of Hepatology 2017 cited by 500

  12. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study

    Authors: , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 247

  13. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

    Authors: , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 181

  14. Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis

    Authors: , , , , , , , , , , , , , - Addiction 2023 cited by 116

  15. A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study

    Authors: , , , , , , , , , , - Journal of Hepatology 2023 cited by 53

  16. Epidemiology and natural history of HCV infection

    Authors: , , - Nature Reviews Gastroenterology & Hepatology 2013 cited by 997

  17. Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs

    Authors: , , , , , , , , , , , , , , , , , - Addiction 2018 cited by 259

  18. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vladimir Chulanov, Mae Dirac, Hannah Han, John W. Ward - ˜The œLancet. Gastroenterology & hepatology 2024 cited by 82

  19. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

    Authors: , , , , , , , , , , , , , , , - The Lancet Global Health 2017 cited by 432

  20. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gerard Estivill Mercade, María Martínez-Martínez, Roy Donnelly, Colette McGrath, Julia Bowman, Lee Trevethan, Katerina Lagios, Luke Grant, Terry Murrell, Nicky Bath, Victor Tawil, Annabelle Stevens, Libby Topp, Alison Churchill, Kate Pinnock, Natasha K. Martin, Steve Drew, Mary Harrod, Angela R. Smith, Ronella Williams, Brigid Cooper, Kelly Somes, Carina Burns, Anoop Kaur, Camilla Lobo, K. D. Conroy, Luke McCredie, Carolyn Café, Jodie Anlezark, William D . Rawlinson, Malinna Yeang, Matthew Wynn, Christiana Willenborg - ˜The œLancet. Gastroenterology & hepatology 2021 cited by 98

  21. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , - International Journal of Drug Policy 2022 cited by 83

  22. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mihály Makara, Ieva Tolmane, Ligita Jančorienė, Sorin Stratulat, Robert Flisiak, Liana Gheorghe, R. Cernat, A. Lakhov, Oksana V. Stanevich, Peter Jarčuška, Markus Peck‐Radosavljevic, Geert Robaeys, Anne Øvrehus, Graham R. Foster, Jussi Sutinen, Martti Färkkilâ, Henna Rautiainen, S. Vuoti, Dimitrinka Nikolova, Jean–Michel Pawlotsky, Jürgen K. Rockstroh, Vana Sypsa, George Papatheodoridis, Sigurður Ólafsson, Eoin R. Feeney, Elisabetta Teti, Carole Seguin‐Devaux, James Pocock, Sarah C. Reiff, NI McDougall, Marc van der Valk, Olav Dalgård, Rui Tato Marinho, John Dillon, Edgar J.G. Peters, Ksenija Bojović, Mojca Matičič, Martin Kåberg, Philip Bruggmann, Brendan Healy, Vui Heng Chong, S. Yi, Joseph D. Tucker, L.R. Pasaribu, Junko Tanaka, Elizabeth A. Ashley, Mustafa Hassan, Noor Syahireen Mohammed, Huan‐Keat Chan, Sarantuya Gidaagaya, Khin Pyone Kyi, Kim Hyung Joon, Bum Sik Chin, P.C. Baladjay, Jia‐Horng Kao, Tanyaporn Wansom, Bernadine Cruz, Barnaby Flower, Esmaeelpour Ehsan, M.A. Mahtab, Lekey Khandu, Ajeet Singh Bhadoria, Maryam Alavi, Praharaj Kc, Saeed Hamid, S. Biryukov, D. Alymbaeva, Arash Alaei, Shokhista Bakieva, Diego Flichman and 86 more - ˜The œLancet. Gastroenterology & hepatology 2024 cited by 66

  23. A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip A. Read, Alisa Pedrana, Alexander Thompson, Joss O’Loan - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 37

  24. Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis

    Authors: , , , , , - ˜The œLancet. Gastroenterology & hepatology 2018 cited by 220